June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Determinants of macular pigment optical density in subjects at high risk for age-related macular degeneration: the LIMPIA Study
Author Affiliations & Notes
  • Marie-Noelle Delyfer
    Ophthalmology, Hopital Pellegrin, Bordeaux, France
    Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
  • Marie Rougier
    Ophthalmology, Hopital Pellegrin, Bordeaux, France
  • Catherine Creuzot-Garcher
    CHU de DIjon, Dijon, France
  • Hélène Savel
    CHU de Bordeaux, Pôle de Santé Publique, Unité de soutien méthodologique à la recherche clinique et épidémiologie (USMR), Bordeaux, France
  • Geneviève Chêne
    CHU de Bordeaux, Pôle de Santé Publique, Unité de soutien méthodologique à la recherche clinique et épidémiologie (USMR), Bordeaux, France
  • Cecile Delcourt
    Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
    : INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
  • Jean-Francois Korobelnik
    Ophthalmology, Hopital Pellegrin, Bordeaux, France
    Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
  • Footnotes
    Commercial Relationships Marie-Noelle Delyfer, Thea Laboratories (F); Marie Rougier, THEA (C), Bausch&Lomb (C), Allergan (C), Kemin (C); Catherine Creuzot-Garcher, None; Hélène Savel, None; Geneviève Chêne, None; Cecile Delcourt, Laboratoires Théa (F), Novartis (C), Bausch+Lomb (C); Jean-Francois Korobelnik, Alcon (C), Allergan (C), Bayer (C), Carl Zeiss Meditec (C), Novartis (C), Thea (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 240. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marie-Noelle Delyfer, Marie Rougier, Catherine Creuzot-Garcher, Hélène Savel, Geneviève Chêne, Cecile Delcourt, Jean-Francois Korobelnik; Determinants of macular pigment optical density in subjects at high risk for age-related macular degeneration: the LIMPIA Study. Invest. Ophthalmol. Vis. Sci. 2013;54(15):240. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We studied the associations of macular pigment optical density (MPOD) with potential determinants (including smoking, body mass index and other cardiovascular risk factors) in subjects with at least one parent affected by neovascular age-related macular degeneration (AMD).

Methods: The Limpia Study is a double-blind, placebo controlled, prospective randomized clinical trial performed in 120 subjects with at least one parent affected by neovascular AMD. To be included, subjects had to be aged 40-70 years, have best-corrected visual acuity (BCVA) greater than 20/25, be free of late AMD and other major eye conditions (severe glaucoma, high myopia, severe retinal disease, cataract surgery…). Subjects having used supplements containing lutein and/or zeaxanthin in the preceding year were not included. Macular pigment optical density (MPOD) was measured by two methods (modified Heidelberg Retinal Analyzer (HRA), Heidelberg, Germany and Visucam 200 MPD, Carl Zeiss Meditec, Germany). Body mass index (BMI, in kg/m2) was calculated from measured weight and height: weight/(height)2. Plasma lipids (total and HDL-cholesterol, triglycerides) were measured from fasting blood samples. Associations of MPOD with potential determinants were assessed by mixed linear models, taking into account the data from both eyes and their correlation.

Results: After adjustment for age and gender, MPOD measured with modified HRA strongly decreased with increasing BMI (p=0.009, p=0.002 and p=0.0004, for MPOD within 0.5°, 1° and 2° respectively). Area of MPOD measured with Visucam MP also decreased with increasing BMI (p=0.002), while other parameters (volume, mean, maximum) showed no significant associations with BMI. Current smokers also tended to have lower MPOD measured with modified HRA, mainly for higher eccentricities (p=0.13, p=0.046, p=0.03 at 0.5°, 1° and 2°, respectively), but not for any MPOD parameters measured with Visucam MP. We observed no significant associations of MPOD with total or HDL-cholesterol.

Conclusions: This study confirms a decrease of macular pigment density in subjects with high BMI and in current smokers, in a population of middle-aged subjects at high risk for AMD.

Keywords: 587 macular pigment • 618 nutritional factors • 412 age-related macular degeneration  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×